Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-17

Clinical Trial Update: Study of Tau Imaging With the Use of [18F]MK-6240 Tracer

View source ↗

Summary

This clinical trial update describes an ongoing study using the tau imaging tracer [18F]MK-6240 to assess tau pathology in Alzheimer’s disease, with enrollment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • [18F]MK-6240 tracer (MK-6240)

Snippet

Sponsor: Tammie L. S. Benzinger, MD, PhD | Conditions: Alzheimer Disease | Status: ENROLLING_BY_INVITATION